Preoperative Presence of Gastric Content in Non-fasting Patients - an Ultrasound Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03685435|
Recruitment Status : Recruiting
First Posted : September 26, 2018
Last Update Posted : January 7, 2019
Using bedside ultrasound, the investigators will examine gastric content in non-fasting patients assigned to rapid sequence intubation (RSI). The procedure will be done immediately before intubation. The percentage of non-fasting patients who actually have gastric content will be determined.
Identifying gastric content is critical because presence increases the risk of pulmonary aspiration during intubation.
|Condition or disease||Intervention/treatment|
|Non-fasting Patients Rapid Sequence Intubation Anesthesia Intubation Complication||Other: Bedside ultrasound|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Preoperative Presence of Gastric Content in Non-fasting Patients - an Ultrasound Study|
|Actual Study Start Date :||January 2, 2019|
|Estimated Primary Completion Date :||July 15, 2019|
|Estimated Study Completion Date :||July 15, 2019|
We will examine non-fasting patients using bedside ultrasound. First we examine the gaster in a supine position. Then we repeat the procedure in a right lateral position.
Other: Bedside ultrasound
Checking for gastric content using bedside ultrasound
- High risk of aspiration [ Time Frame: Immediately before intubation ]Detection of solids, or more than 1,5 mL/kg clear fluid in the gaster
- Low risk of aspiration [ Time Frame: Immediately before intubation ]Detection of empty stomach, or less than 1,5 mL/kg clear fluid in the gaster
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03685435
|Contact: Vegard Dahl, PhDfirstname.lastname@example.org|
|Contact: Felix Haidl, Cand.email@example.com|
|Akershus University Hospital||Recruiting|
|Lørenskog, Akershus, Norway, 1478|
|Contact: Vegard Dahl, dr.med 47-91674604 firstname.lastname@example.org|
|Contact: Felix Haidl, Cand.med 47-46656707 email@example.com|
|Sub-Investigator: Linn R Johnsen, Stud.med|
|Sub-Investigator: Ingvild Holtan-Hartwig, Stud.med|
|Principal Investigator: Vegard Dahl, dr.med|
|Principal Investigator:||Vegard Dahl, PhD||University Hospital, Akershus|